0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn%E2%80%99s%20disease" gave back 49354 results.
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Cimzia (certolizumab) Drug is a biologic medication that belongs to the class of drugs known as TNF-alpha inhibitors. It is used to treat a variety...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Entyvio (vedolizumab) is a prescription drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The drug...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Integrin Alpha 4 - Pipeline Review, H2 2019 Summary Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4)...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
The global Incontinence & Ostomy Care market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Filter By Report Date
Filter By Industry
Filter By Country
- Global (48908) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Markets (1) Apply Emerging Markets filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
